Key result
Endothelial ILK deletion in mice impairs cardiac function and induces coronary microvascular disease features.
Why the study?
Endothelial dysfunction is an early event in coronary microvascular disease, but the specific role of endothelial ILK in cardiac function remains to be fully elucidated.
Does endothelial ILK deletion cause coronary microvascular dysfunction and adverse cardiac remodelling in preclinical models?
Does endothelial ILK deletion cause coronary microvascular dysfunction and adverse cardiac remodelling in preclinical models?
Endothelial ILK plays a crucial role in maintaining coronary microvascular function and preventing adverse cardiac remodelling by inhibiting endothelial-to-mesenchymal transition.
Endothelial ILK may protect against microvascular dysfunction and remodeling; hypothesis-generating for CMD therapies pending human validation.
Endothelial dysfunction is an early event in coronary microvascular disease. Integrin-linked kinase (ILK) prevents endothelial nitric oxide synthase (eNOS) uncoupling and, thus, endothelial dysfunction. However, the specific role of endothelial ILK in cardiac function remains to be fully elucidated. We hypothesised that endothelial ILK plays a crucial role in maintaining coronary microvascular function and contractile performance in the heart. We generated an endothelial cell-specific ILK conditional knock-out mouse (ecILK cKO) and investigated cardiovascular function. Coronary endothelial ILK deletion significantly impaired cardiac function: ejection fraction, fractional shortening and cardiac output decreased, whilst left ventricle diastolic internal diameter decreased and E/A and E/E' ratios increased, indicating not only systolic but also diastolic dysfunction. The functional data correlated with extensive extracellular matrix remodelling and perivascular fibrosis, indicative of adverse cardiac remodelling. Mice with endothelial ILK deletion suffered early ischaemic-like events with ST elevation and transient increases in cardiac troponins, which correlated with fibrotic remodelling. In addition, ecILK cKO mice exhibited many features of coronary microvascular disease: reduced cardiac perfusion, impaired coronary flow reserve and arterial remodelling with patent epicardial coronary arteries. Moreover, endothelial ILK deletion induced a moderate increase in blood pressure, but the antihypertensive drug Losartan did not affect microvascular remodelling whilst only partially ameliorated fibrotic remodelling. The plasma miRNA profile reveals endothelial-to-mesenchymal transition (endMT) as an upregulated pathway in endothelial ILK conditional KO mice. Our results show that endothelial cells in the microvasculature in endothelial ILK conditional KO mice underwent endMT. Moreover, endothelial cells isolated from these mice and ILK-silenced human microvascular endothelial cells underwent endMT, indicating that decreased endothelial ILK contributes directly to this endothelial phenotype shift. Our results identify ILK as a crucial regulator of microvascular endothelial homeostasis. Endothelial ILK prevents microvascular dysfunction and cardiac remodelling, contributing to the maintenance of the endothelial cell phenotype.
No takes yet. Share an insight, caveat, or question.
Reventún et al. (2023) studied Coronary microvascular disease. Endothelial ILK deletion was evaluated on Cardiac function, coronary microvascular function, and endothelial-to-mesenchymal transition. Endothelial ILK deletion in mice impaired cardiac function, induced coronary microvascular disease features, and promoted endothelial-to-mesenchymal transition.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: